Why federal chemical regulation is broken: new science on BPA and low-dose exposure
The American Medical Association and the Endocrine Society have agreed that current chemical regulation and risk assessment is not adequate to protect the public from endocrine disrupting chemicals such as bisphenol A (BPA).
The American Medical Association and the Endocrine Society have agreed that current chemical regulation and risk assessment is not adequate to protect the public from endocrine disrupting chemicals such as bisphenol A (BPA). They resolve that “Policy should be based on comprehensive data covering both low-level and high-level exposures.”
The Endocrine Society: “The Endocrine Society is concerned that the public may be placed at risk because critical information about the potential health effects of endocrine disrupting chemicals is being overlooked in the development of federal guidelines and regulations. This new resolution marks an important step in engaging policymakers to enact policies that decrease public exposure to these potentially harmful chemicals.” — Robert Vigersky, MD, Endocrine Society President
Links:
